The chemical class known as PRAME like-6 activators encompasses a range of compounds that can influence the regulation of gene expression through epigenetic modifications. The primary mode of action for these activators involves the alteration of the cellular epigenetic landscape, a key factor in the control of gene activity. Histone deacetylase (HDAC) inhibitors constitute a significant portion of this class. These molecules can increase histone acetylation levels, leading to a more relaxed chromatin state that can facilitate the transcription of various genes, including those that are typically underexpressed. DNA methyltransferase inhibitors form another category within this class, and these compounds can induce the demethylation of DNA, a process that can remove repressive marks from gene promoters and enhancers, thus promoting gene expression.
Additionally, PRAME like-6 activators include compounds that modify signaling pathways, affecting protein stability and gene expression profiles. For instance, some activators target proteasome pathways, which can lead to stabilization of proteins that regulate gene expression. Others inhibit pathways such as NF-kB, which are involved in cellular responses to stimuli and can have wide-ranging effects on gene transcription regulation. By influencing these pathways, the activators can bring about changes in the expression levels of a variety of genes, including those involved in cell proliferation, differentiation, and survival. The cumulative effect of these compounds on the cellular epigenetic and signaling environment can result in the upregulation of genes, including PRAME like-6, which may otherwise be silent or expressed at low levels in certain contexts. The precise mechanisms by which these activators exert their effects on PRAME like-6 expression are complex and require a nuanced understanding of cellular biochemistry and molecular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to demethylation of gene promoter regions, could possibly activate PRAMEL6 by facilitating gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can increase histone acetylation, could possibly activate transcription of PRAMEL6 by promoting a more open chromatin state. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
An inhibitor of the proteasome and NF-kB pathway, could possibly activate PRAMEL6 by impacting protein stability and modifying signaling pathways. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Another histone deacetylase inhibitor that can alter chromatin structure and could possibly activate PRAMEL6 by increasing gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can promote histone acetylation and could possibly activate the transcription of PRAMEL6. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A hypomethylating agent that can induce DNA demethylation and could possibly activate silenced genes, including PRAMEL6. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A broad-spectrum histone deacetylase inhibitor that can affect gene transcription and could possibly upregulate PRAMEL6. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
An HDAC inhibitor that can alter gene expression through chromatin remodeling, could possibly enhance transcription of PRAMEL6. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
An HDAC inhibitor that can modulate chromatin structure and could possibly affect PRAMEL6 expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
An HDAC inhibitor that can impact histone acetylation and could possibly modulate gene expression, including PRAMEL6. | ||||||